Out of Stock

This item is currently unavailable

The 2025-2030 World Outlook for Primary Brain Tumor Diagnosis and Treatments

Out of Stock

Price data last checked 151 day(s) ago - refreshing...

View at Amazon

One email. No newsletter. No nudges.

Gone for 151 days. Could come back at any time — we're watching for you.

Out of stock 151 days · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
02 April 2024

Similar Products You Might Like

The 2025-2030 World Outlook for Brain Tumor Diagnosis and Treatments
99% match

The 2025-2030 World Outlook for Brain Tumor Diagnosis and Treatments

Out of Stock 11 Jan 2026
The 2023-2028 World Outlook for Brain Tumor Diagnosis and Treatments
99% match

The 2023-2028 World Outlook for Brain Tumor Diagnosis and Treatments

Out of Stock 06 Jan 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China
99% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China

£495.00 12 Mar 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China
99% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in Japan
98% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in the United States
98% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in the United States

£520.00 10 Jan 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in the United States
98% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in the United States

£520.00 11 Jan 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in India
98% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in India

£515.00 24 Feb 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments for US Zip Codes
98% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments for US Zip Codes

£490.00 24 Jan 2026
The 2023 Report on Primary Brain Tumor Diagnosis and Treatments: World Market Segmentation by City
98% match

The 2023 Report on Primary Brain Tumor Diagnosis and Treatments: World Market Segmentation by City

£795.00 04 Feb 2026
The 2023 Report on Cell-Based Brain Tumor Therapeutics: World Market Segmentation by City
97% match

The 2023 Report on Cell-Based Brain Tumor Therapeutics: World Market Segmentation by City

£795.00 12 Jan 2026
IntechOpen - Diagnostic Techniques and Surgical Management of Brain Tumors
97% match

IntechOpen - Diagnostic Techniques and Surgical Management of Brain Tumors

IntechOpen

£147.51 17 Apr 2026
Brain Tumors: Advancements in Diagnostics and Innovative Therapies
97% match

Brain Tumors: Advancements in Diagnostics and Innovative Therapies

CRC Press

£69.01 25 Feb 2026
Primary Brain Tumors in Adults: Advances in Mechanistic Understanding, Evaluation, and Management: Volume 166 (Advances in Cancer Research, Volume 166)
97% match

Primary Brain Tumors in Adults: Advances in Mechanistic Understanding, Evaluation, and Management: Volume 166 (Advances in Cancer Research, Volume 166)

Academic Press

£105.77 11 Feb 2026
Clinical Management and Evolving Novel Therapeutic Strategies for Patients with Brain Tumors
96% match

Clinical Management and Evolving Novel Therapeutic Strategies for Patients with Brain Tumors

IntechOpen

£157.23 21 Apr 2026
IntechOpen Brain Tumors - Current and Emerging Strategies
96% match

IntechOpen Brain Tumors - Current and Emerging Strategies

IntechOpen

£130.98 18 Apr 2026
Molecular Considerations and Evolving Surgical Management Issues in the Treatment of Patients with a Brain Tumor
96% match

Molecular Considerations and Evolving Surgical Management Issues in the Treatment of Patients with a Brain Tumor

IntechOpen

£137.70 12 Apr 2026
The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in India
96% match

The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in India

£515.00 26 Jan 2026
The 2023-2028 Outlook for Pseudotumor Cerebri in the United States
96% match

The 2023-2028 Outlook for Pseudotumor Cerebri in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Pseudotumor Cerebri in India
96% match

The 2023-2028 Outlook for Pseudotumor Cerebri in India

£515.00 31 Jan 2026
The 2023-2028 World Outlook for Pseudotumor Cerebri
96% match

The 2023-2028 World Outlook for Pseudotumor Cerebri

Out of Stock 09 Jan 2026
Clinical Management of Brain Tumor
96% match

Clinical Management of Brain Tumor

Hayle Medical

£51.50 12 Apr 2026
The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in China
96% match

The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in China

£495.00 10 Mar 2026
The 2023-2028 Outlook for Pseudotumor Cerebri in China
96% match

The 2023-2028 Outlook for Pseudotumor Cerebri in China

£495.00 25 Jan 2026